EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement

Feb 05, 2020, 01:45 PM

The Stock Day Podcast welcomed EastGate Biotech (ETBI)(“the Company”), a company that focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are based on natural therapies absorbed by the body. CEO of the Company, Anna Gluskin, and President of the Company, Rose Perri, joined Stock Day host Everett Jolly.